Powered By Bing

Supplementary Information

Gene Expression Profiling of Pediatric Acute Myelogenous Leukemia

Section V: Outcome Analysis

Table S16. Patient outcome data used in training set

Case identifier Studya Relapseb No Relapsec
inv16- #02 AML87 - 234
inv16- #03 AML87 - 4929
inv16- #05 AML91 - 3598
inv16- #06 AML91 - 1553
inv16- #08 AML97 - 1136
inv16- #09 AML87 - 4610
inv16- #10 AML97 496 -
inv16- #11 AML97 - 684
inv16- #12 AML97 - 162
MLL- #01 AML87 252 -
MLL- #03 AML91 0 -
MLL- #04 AML91 378 -
MLL- #05 AML91 - 3445
MLL- #08 AML91 - 2347
MLL- #09 AML91 710 -
MLL- #10 AML91 - 2293
MLL- #11 AML91 212 -
MLL- #12 AML91 - 1822
MLL- #14 AML97 - 37
MLL- #16 AML97 - 175
MLL- #17 AML97 - 927
MLL- #18 AML97 471 -
MLL- #19 AML97 - 404
MLL- #23 AML97 - 529
MLL-#21 AML87 - 4549
Other- #02 AML87 386 -
Other- #03 AML87 417 -
Other- #05 AML87 458 -
Other- #07 AML87 0 -
Other- #08 AML87 267 -
Other- #11 AML87 - 4306
Other- #12 AML87 0 -
Other- #13 AML91 1596 -
Other- #15 AML91 1951 -
Other- #16 AML91 - 2688
Other- #18 AML97 - 133
Other- #19 AML91 - 2354
Other- #20 AML91 212 -
Other- #21 AML91 268 -
Other- #24 AML97 519 -
Other- #25 AML97 - 1927
Other- #26 AML97 - 1790
Other- #27 AML97 0 -
Other- #28 AML97 - 272
Other- #31 AML97 - 1235
Other- #33 AML87 0 -
Other- #35 AML91 0 -
Other- #36 AML97 - 916
Other- #38 AML97 464 -
Other- #40 AML97 115 -
Other- #41 AML97 167 -
Other- #43 AML97 - 203
Other- #44 AML91 0 -
Other- #45 AML91 146 -
Other- #6 AML87 0 -
Other-M7- #02 AML87 - 4040
Other-M7- #04 AML97 - 1967
Other-M7- #05 AML97 - 1746
Other-M7- #06 AML97 179 -
Other-M7- #08 AML91 0 -
t(8;21)- #01 AML87 - 4241
t(8;21)- #03 AML87 569 -
t(8;21)- #04 AML87 0 -
t(8;21)- #06 AML91 - 3832
t(8;21)- #08 AML97 891 -
t(8;21)- #09 AML97 415 -
t(8;21)- #11 AML97 - 1165
t(8;21)- #12 AML97 401 -

aTreatment protocols: AML87, AML91, and AML97 are St.Jude Children’s Research Hospital institutional protocols.
bShown is the number of days from diagnosis to relapse. “0” indicates that the patient never achieved a complete remission.
cShown is the number of days from diagnosis to the last follow-up